Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07225439

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Clinical Trial Site, Cleveland

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
Cleveland Clinic, Cleveland

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Cincinnati Children's Hospital Medical Center, Cincinnati

Се регрутираФаза 1/2

12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

University of Cincinnatti Medical Center, Cincinnatti

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT06528301

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

The Ohio State University Wexner Medical Center, Columbus

Се регрутираФаза 1/2

Возраст од 13 до 90 · Сите полови · Ажурирано 6.8.2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Oncology Hematology Care Clinical Trials, Cincinnati
University of Cincinnati, Cincinnati
Cleveland Clinical Taussig Cancer Center, Cleveland

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

The Ohio State University Wexner Medical Center James Cancer, Columbus

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 13.7.2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

The Ohio state University, Columbus

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
и уште 3

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 6.7.2026 · NCT01351545

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

Се регрутираФаза 1

Возраст од 18 до 65 · Сите полови · Ажурирано 25.6.2026 · NCT06447376

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

Се регрутираФаза 1

Возраст 2 и постари · Сите полови · Ажурирано 29.5.2026 · NCT05418088

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

Се регрутираФаза 1

Возраст 13 и постари · Сите полови · Ажурирано 5.5.2026 · NCT04771572

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

The Ohio State University, Columbus

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 24.4.2026 · NCT06801002

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Cleveland Clinic, Cleveland

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 16.4.2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Indu and Raj Soin Medical Center, Beavercreek
Strecker Cancer Center-Belpre, Belpre
Dayton Physician LLC - Englewood, Dayton
и уште 9

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 17.3.2026 · NCT06418204

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Ohio State University Comprehensive Cancer Center, Columbus

Се регрутираФаза 4

Возраст 18 и постари · Сите полови · Ажурирано 2.3.2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Ohio State University Comprehensive Cancer Center, Columbus

Се регрутираФаза 4

Возраст 18 и постари · Сите полови · Ажурирано 2.3.2026 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

Gabrail Cancer & Research Center, Canton
The Ohio State University - The James Cancer Hospital, Columbus

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Taylor Cancer Research Center, Maumee

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.12.2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Cincinnati
Massive Bio SYNERGY-AI site, Columbus
Massive Bio SYNERGY-AI site, Mayfield Heights

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

University Hospitals Cleveland Medical Center, Cleveland
The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 2.10.2025 · NCT05780034

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

University Hospitals Cleveland, Cleveland

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 3.6.2025 · NCT06119685

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

University Hospitals Seidman Cancer Center, Cleveland
Taussig Cancer Institute | Cleveland Clinic, Cleveland

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 21.10.2024 · NCT05312801

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

University of Cincinnati, Cincinnati
The Ohio State University Comprehensive Cancer Center, Columbus

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 4.8.2022 · NCT04502394

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.